www.fdanews.com/articles/130833-baxter-presents-data-from-interim-analyses-of-phase-iii-clinical-trial

Baxter Presents Data From Interim Analyses of Phase III Clinical Trial

October 6, 2010

Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency who received Baxter’s HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies in Istanbul, Turkey.
MarketWatch